Fecha de publicación: 16/04/2020 Fuente: WIPO "apis cerana" The present disclosure provides, inter alia, methods for treating infectious diseases, e.g., a microsporidia infection caused by Nosema ceranae, in a subject such as, e.g., a honeybee, using proteasome inhibitors including Ixazomib. Methods for monitoring the progress of a microsporidia infection in a subject, and methods for measuring the intensity of a microsporidia infection in a subject, are also provided.